Recent News

• 03.18.2026 - Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
• 03.09.2026 - Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
• 02.12.2026 - Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference

Recent Filings

• 03.11.2026 - S-3 Registration statement under Securities Act of 1933
• 03.09.2026 - 8-K Current report
• 03.09.2026 - EX-99.1 EX-99.1
• 03.09.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 144 Report of proposed sale of securities
• 02.25.2026 - EX-99.1 EX-99.1
• 02.25.2026 - 8-K Current report
• 02.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.18.2026 - 4 Statement of changes in beneficial ownership of securities